Sura-vec, a potential one-time treatment, uses the NAV AAV8 vector to inhibit VEGF, targeting wet AMD and other retinal conditions.

A young surgeon reflects on training, technology, and the human side of adopting new excimer laser platforms. There are very few ...

Early and aggressive treatment of dry eye disease can prevent progression and preserve ocular health, especially in glaucoma patients. A multifaceted approach is necessary for managing meibomian gland ...

The tension between STAAR and Broadwood Partners continues as both have issued further statements for and against the proposed merger between STAAR and Alcon, respectively. These statements come weeks ...

Intravitreal RPCs showed positive effects on electroretinography, optomotor response, and contrast sensitivity in a rat model of diabetic retinopathy. The procedure showed positive effects on the ...

The YOURS Committee supports young retina specialists with educational initiatives, professional development, and networking opportunities. Learn how the YOURS Committee empowers young retina ...

Privosegtor (also known as OCS-05) is a “first-in-class peptoid small molecule” for neuroprotective therapy for acute optic neuritis (AON), non-arteritic anterior ischemic optic neuropathy (NAION), ...

From early experiences in India to fellowship training at Wills Eye Hospital, Dr. Ansari discusses how ophthalmologists can make a lasting impact worldwide.

Treatment-Resistant AMD and Diabetic Macular EdemaWith High-Dose Aflibercept Summary. This presentation examines the management of treatment-resistant retinal conditions using hig ...

Keratometry measures the radius of curvature of the cornea, specifically the central zone. This measurement helps determine the cornea’s refractive power and identify any irregularities, such as ...

OTX-TKI (Axpaxli) offers a novel approach for wet macular degeneration with sustained drug release up to 9 months via a hydrogel platform. Two phase 3 trials, SOL-1 and SOL-R, evaluate Axpaxli's ...

The EURETINA meeting attracted over 11,000 attendees, showcasing advancements in retinal disease treatments, including gene therapy and implants for geographic atrophy. Gene therapy offers a potential ...